U.S., Feb. 25 -- ClinicalTrials.gov registry received information related to the study (NCT06842030) titled 'Feasibility Trial of Darwin OncoTreat and OncoTarget Precision Medicine Testing' on Jan. 07.
Brief Summary: This is a feasibility trial to assess use of OncoTarget and OncoTreat testing in a basket design of patients with oligmetastasis across various solid tumor histology. Eligible oligometastatic patients that are receiving radiation therapy (n=20) will undergo mandatory tumor biopsy prior to precision medicine testing. Formalin fixed paraffin embedded tissue with >50% tumor will be sent to the Laboratory of Personalized Genomic Medicine at Columbia University Medical Center for Darwin OncoTarget and OncoTreat testing. This will b...